Combination trial designs: efficient, effective and tolerable regimens
Combination trial designs: efficient, effective and tolerable regimens
Patient perspectives in precision medicine: 'No innovation about us without us'
Critique of the SHIVA trial
Affordable next generation sequencing to support decision making
Characterisation of somatic mutations using patient RNASeq profiles
New targets in personalised therapy for patients with lung cancer
Editor's ASCO 2016 Roundup
Sequencing multiple myeloma reveals a complex landscape of genetic lesions
Karyotyping a CLL subset with ibrutinib susceptibility
Chemo-genomic interrogation reveals JAK sensitive subgroup in AML
The role of AKT in chronic lymphocytic leukaemia transformation to Richter's syndrome
Older patients with AML benefit greatly from SGN-CD33 and HMA therapy combo